| Stage | ARKO | % of rev | ECPG | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $2.3B | 100.00% | $421M | 100.00% | ARKO ×5.58 |
| Gross profit | $525M | 22.35% | $301M | 71.58% | ECPG +49.2pp |
| Operating income | $30M | 1.29% | $187M | 44.42% | ECPG +43.1pp |
| Pre-tax income | $16M | 0.70% | $83M | 19.69% | ECPG +19.0pp |
| Net income | $9M | 0.40% | $64M | 15.21% | ECPG +14.8pp |
| Stage | ARKO | ECPG | Gap · A − B |
|---|---|---|---|
| Revenue | $2.3B100.00% | $421M100.00% | ARKO ×5.58 |
| Gross profit | 22.35%$525M | 71.58%$301M | ECPG +49.2pp |
| Operating income | 1.29%$30M | 44.42%$187M | ECPG +43.1pp |
| Pre-tax income | 0.70%$16M | 19.69%$83M | ECPG +19.0pp |
| Net income |
| 0.40%$9M |
| 15.21%$64M |
| ECPG +14.8pp |
No disclosed counterparties: ECPG.
None